Other Clinical Trial - Multiple Rising Does Study (Subcutaneous Doses) of

See also
Status	Clinical Trial	Phase
Completed	`NCT01356511` - High-dose Dexamethasone Versus Conventional Dose Prednisone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)	Phase 4
Completed	`NCT00540423` - Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)	Phase 3
Completed	`NCT00372892` - Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)	Phase 2
Not yet recruiting	`NCT03252457` - Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP	Phase 3
Completed	`NCT00151840` - Efficacy and Safety of IVIG-L in ITP Patients	Phase 3
Recruiting	`NCT05438875` - The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9	Phase 3
Completed	`NCT02281370` - Drug-drug Interaction Study of Eltrombopag and Cyclosporine in Healthy Subjects	Phase 1
Terminated	`NCT00547066` - Study of Veltuzumab (hA20) at Different Doses in Patients With ITP	Phase 1/Phase 2
Completed	`NCT00370331` - RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag	Phase 3
Completed	`NCT00828750` - Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)	Phase 3
Completed	`NCT00487968` - Eltrombopag Taste Testing in Healthy Adult Volunteers	Phase 1
Withdrawn	`NCT01317966` - Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia	N/A
Not yet recruiting	`NCT03443570` - Rituximab Combining Bortezomib Versus Rituximab in Management of ITP	Phase 3
Completed	`NCT01610180` - Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)	Phase 2
Completed	`NCT02201290` - A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)	Phase 3
Completed	`NCT00220727` - Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP	Phase 2
Completed	`NCT02334813` - Daily Prednisone Versus Pulsed Dexamethasone in Treatment-naïve Adult Patients With Immune Thrombocytopenia	Phase 3
Completed	`NCT02891109` - Regulatory B Cells and Chronic Immune Thrombocytopenia	N/A
Completed	`NCT00706342` - Pilot Study of be Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)	Phase 2
Completed	`NCT03258866` - The Study of Different Dose Rituximab in the Treatment of ITP	Phase 4

NCT number	NCT02009761
Study type	Interventional
Source	Boehringer Ingelheim
Contact
Status	Terminated
Phase	Phase 1
Start date	December 18, 2013
Completion date	April 26, 2016

Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms